What is RVMD's five-year median P/E?

There are not enough weekly readings yet for a five-year median P/E.

Does a low historical rank mean a stock is a buy?

No. The rank compares RVMD only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Revolution Medicines Inc (RVMD) valuation

Health Care

$188.72

Latest weekly close · Market cap $39.8B

Revolution Medicines has no P/E right now because its earnings over the last twelve months are negative (as of Oct 29, 2026).

No P/S: recent financial data is missing.
No EV/Sales: recent financial data is missing.
No EV/EBITDA: recent financial data is missing.

No P/E chart for RVMD right now

RVMD has no weekly P/E history to chart yet.

P/E

n/mnot ranked

P/E needs positive earnings to be ranked.

Growth, last 12 months vs the year before

Revenue: n/m
EPS: n/m

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends. EPS was not positive in this window, so it is left out.

PriceRevenue, last 12 months100 = first reading

P/E at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

RVMD P/E at each year-end
Year-end	P/E	5-year percentile	P/S	EV/Sales	EV/EBITDA
Dec 29, 2025	n/m	Too little history	n/m	n/m	n/m
Dec 30, 2024	n/m	Too little history	n/m	n/m	n/m
Dec 25, 2023	n/m	Too little history	119.7×	88.6×	n/m
Dec 26, 2022	n/m	Too little history	68.4×	46.2×	n/m

Health Care peers on P/E

Each percentile compares a stock with its own last five years.

Compare RVMD with peers

Health Care peers of RVMD on P/E
Stock	P/E	Versus its own history	5-year percentile
ABBVAbbVie	80.8×	Above its usual range	76
AMGNAmgen	28.1×	Above its usual range	80
ARWRArrowhead Pharmaceuticals Inc	n/m	Not ranked	n/m, not ranked
BBIOBridgebio Pharma Inc	n/m	Not ranked	n/m, not ranked
BIIBBiogen	105.2×	Historically high	100

Appears in

Sector: Health Care
Screens: Nuclear Stocks: Valuation Screen
Semiconductor Equipment Stocks: Valuation Screen

Screen Health Care stocks the same way

Research on RVMD

No articles about RVMD yet. How valuation percentiles work

Loading peers and related research…

About this history

What is RVMD's current P/E?: Revolution Medicines has no P/E right now because its earnings over the last twelve months are negative (as of Oct 29, 2026).
What is RVMD's five-year median P/E?: There are not enough weekly readings yet for a five-year median P/E.
Does a low historical rank mean a stock is a buy?: No. The rank compares RVMD only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.